Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02105662
What this trial is testing

An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus:C-EDGE CO-INFXN (MK-5172-061)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 218
Not applicableUnknownNCT05170490
What this trial is testing

Long Term Follow up of Chronic HCV Patients Receiving DAAS

Who this might be right for
Chronic Hepatitis c
Sohag University 100
Large-scale testing (Phase 3)Study completedNCT00048724
What this trial is testing

Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)

Who this might be right for
Chronic Hepatitis CCirrhosis
Merck Sharp & Dohme LLC 631
Early research (Phase 1)Study completedNCT01889849
What this trial is testing

Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers

Who this might be right for
Chronic Viral Hepatitis C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 32
Post-approval studies (Phase 4)Study completedNCT03781726
What this trial is testing

Multi-center Study to Transplant Hepatitis-C Infected Kidneys

Who this might be right for
Renal Failure ChronicHepatitis C
Raymond Chung 30
Post-approval studies (Phase 4)Study completedNCT03111108
What this trial is testing

Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)

Who this might be right for
Hepatitis C Virus (HCV) Infection
Merck Sharp & Dohme LLC 117
Post-approval studies (Phase 4)Study completedNCT01413360
What this trial is testing

The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients

Who this might be right for
Chronic HepatitisChronic Hepatitis CChronic Alcoholic Hepatitis
Seoul National University Hospital 10
Not applicableUnknownNCT03268317
What this trial is testing

Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs

Who this might be right for
Hepatitis C
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT02476617
What this trial is testing

Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a
AbbVie 25
Testing effectiveness (Phase 2)Study completedNCT01331850
What this trial is testing

Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 381
Early research (Phase 1)Study completedNCT01879462
What this trial is testing

A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 47
Testing effectiveness (Phase 2)Study completedNCT04019717
What this trial is testing

Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis CHepatitis C, ChronicChronic Hepatitis C+2 more
Atea Pharmaceuticals, Inc. 10
Post-approval studies (Phase 4)Study completedNCT01364090
What this trial is testing

A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 93
Not applicableUnknownNCT00294489
What this trial is testing

Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALT

Who this might be right for
Chronic Hepatitis C Virus Infection
Hadassah Medical Organization 500
Testing effectiveness (Phase 2)UnknownNCT01603108
What this trial is testing

Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant

Who this might be right for
Hepatitis C
Columbia University 59
Large-scale testing (Phase 3)Study completedNCT00038974
What this trial is testing

Hepatitis C Antiviral Resistance in African-Americans

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 401
Large-scale testing (Phase 3)Study completedNCT00527540
What this trial is testing

Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tehran Hepatitis Center 60
Post-approval studies (Phase 4)Study completedNCT02580474
What this trial is testing

The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure

Who this might be right for
Hepatitis C
Myeong Jun Song 21
Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Post-approval studies (Phase 4)Study completedNCT06922643
What this trial is testing

Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital

Who this might be right for
Chronic Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 100
Next Page